Engineered Treg cells: The heir to the throne of immunotherapy
A Stucchi, F Maspes, E Montee-Rodrigues… - Journal of …, 2023 - Elsevier
Recently, increased interest in the use of Tregs as adoptive cell therapy for the treatment of
autoimmune diseases and transplant rejection had led to several advances in the field …
autoimmune diseases and transplant rejection had led to several advances in the field …
Engineered Treg cells: The heir to the throne of immunotherapy.
A Stucchi, F Maspes, E Montee-Rodrigues… - Journal of …, 2023 - europepmc.org
Recently, increased interest in the use of Tregs as adoptive cell therapy for the treatment of
autoimmune diseases and transplant rejection had led to several advances in the field …
autoimmune diseases and transplant rejection had led to several advances in the field …
Engineered Treg cells: The heir to the throne of immunotherapy
A Stucchi, F Maspes, E Montee-Rodrigues… - Journal of …, 2023 - Elsevier
Recently, increased interest in the use of Tregs as adoptive cell therapy for the treatment of
autoimmune diseases and transplant rejection had led to several advances in the field …
autoimmune diseases and transplant rejection had led to several advances in the field …
Engineered Treg cells: The heir to the throne of immunotherapy
A Stucchi, F Maspes, E Montee-Rodrigues… - Journal of … - pubmed.ncbi.nlm.nih.gov
Recently, increased interest in the use of Tregs as adoptive cell therapy for the treatment of
autoimmune diseases and transplant rejection had led to several advances in the field …
autoimmune diseases and transplant rejection had led to several advances in the field …